Development of anti-HBs in patients with chronic hepatitis B after liver transplantation using lamivudine prophylaxis : the possible role of adoptive immunity transfer

2003 ◽  
Author(s):  
Tak-kwan, James Fung
2001 ◽  
Vol 233 (2) ◽  
pp. 276-281 ◽  
Author(s):  
Chung-Mau Lo ◽  
Siu-Tim Cheung ◽  
Ching-Lung Lai ◽  
Chi-Leung Liu ◽  
Irene Oi-Lin Ng ◽  
...  

1999 ◽  
Vol 67 (9) ◽  
pp. S634
Author(s):  
C M Lo ◽  
S T Fan ◽  
C L Lai ◽  
C L Liu ◽  
M F Yuen ◽  
...  

2017 ◽  
Vol 9 (1) ◽  
pp. 79-84 ◽  
Author(s):  
B Wang ◽  
K Agarwal ◽  
D Joshi

Chronic hepatitis B infection is a global public health problem associated with significant morbidity and mortality. Persistent infection may evolve to liver cirrhosis and hepatocellular carcinoma, and hepatitis B-related liver disease is a common indication for liver transplantation. Patients with advanced liver disease should be treated with antiviral therapy which may result in clinical improvement. The management of patients after liver transplant then focuses on preventing hepatitis B recurrence in the graft. With the introduction of prophylactic treatment, patient and graft survival has improved significantly. In this review, we will discuss the management of patients with hepatitis B-related cirrhosis, both compensated and decompensated. We also review the management of hepatitis B after liver transplantation.


2013 ◽  
Vol 19 (8) ◽  
pp. 887-895 ◽  
Author(s):  
Robert Perrillo ◽  
Maria Buti ◽  
Francois Durand ◽  
Michael Charlton ◽  
Adrian Gadano ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document